Year 2000 Lynk Biotechnologies was spun off from National University of Singapore (NUS) with ~S$1 million investment from angel investors.
Year 2002 Launch of Biolyn Hair Serum.
Year 2003 Biolyn Hair Serum technology sold to Lo Hong Ka (HK).
Year 2003 Launch of TGC (Transdermal Glucosamine Cream) (for joint health).
Year 2004 Launch of TGC Plus Capsaicin.
Year 2004 Patent on "Novel Ligands And Methods For Preparing The Same" granted in Singapore.
Year 2004 Incorporation of MediLynk Pte Ltd as a subsidiary with S$2.5 million investment from Whiterock Investment.
Year 2005 Launch of ANDRO Cream For Men (for male vitality) and Oestro Cream (for bust firming).
Year 2005 Successful completion of Phase I Clinical Trial for TGC at the Singapore Changi General Hospital.
Year 2005 Investment of S$6 million into Lynk by a group of private investors led by Mr. Lim Kim Hai.
Year 2005 Incorporation of DynaLynk Pharma Pte Ltd, a joint venture with Dynavest Pte Ltd to expand manufacturing capability.
Year 2006 Development of trans-epidermal T-MAX cream (to relieve pain and itch).
Year 2007 Successful completion of Phase II Clinical Trial For TGC in Indonesia (at the Faculty of Medicine - University of Indonesia, and the Cipto Mangunkusumo Central Hospital, Jakarta, Indonesia Hospital).
Year 2008 DynaLynk Pharma Pte Ltd attained pharmaceutical GMP (Good Manufacturing Practice) certification accredited by the Health Sciences Authority of Singapore (HSA).
Year 2010 Launch of JUMPSTART Instant Energy Cream.
Year 2011 Launch of TummyTuck Slimming Cream.